An early tailored cognitive behavioural therapy intervention for depre

Other measures (1)

Background and study aims Multiple sclerosis (MS) is a condition that causes a wide range of different symptoms, from vision, arm and leg movements, balance or sensation. It can cause mild to serious disabilities. Compared to other chronic diseases and neurological (brain) disorders, rates of depression in individuals with MS is high, in particular around the time of diagnosis. To our knowledge there is no research, in Australia or internationally, specifically examining the psychological treatment of individuals presenting with psychological concerns in individuals within 5-years post Multiple Sclerosis diagnosis (considered newly diagnosed). The aim of this study is to examine the use of an early tailored Cognitive Behavioural Therapy (CBT) (a type of talking therapy that helps individuals learn skills targeting their thinking and behaviour) for depression in individuals newly diagnosed with Multiple Sclerosis. Who can participate? Adults aged 18 to 65 who are diagnosed with MS in the last five years. What does the study involve? Participants are randomly allocated to one of two groups. Those in the first group receive a specialised CBT therapy which helps them learn skills to target their thinking and behaviour. Those in the second group receive a supportive listening based treatment that helps participants express themselves in a non-judgmental and empathetic environment. Both groups attend the therapy for one an hour a week for eight weeks. Participants are followed up at three and six months to assess their depressive symptoms. What are the possible benefits and risks of participating? Participants may benefit from speaking a psychologist about their concerns and learning skills to effectively manage their depressive, anxiety, pain and fatigue symptoms. There are no anticipated risks with participating. Where is the study run from? 1. The Royal Melbourne Hospital (Australia) 2. St Vincent's Hospital Melbourne (Australia) When is the study starting and how long is it expected to run for? May 2016 to January 2024 Who is funding the study? MS Research Australia (Australia) Who is the main contact? Dr Litza Kiropoulos litzak@unimelb.edu.au